Cargando…
Endocan as a potential marker in diagnosis and predicting disease severity in COVID-19 patients: a promising biomarker for patients with false-negative RT-PCR
BACKGROUND: Endothelial-specific molecule 1 (endocan) has emerged as an inflammatory biomarker in recent years. The purpose of this study was to investigate the diagnostic value of serum endocan levels in the prediction of COVID-19 disease among patients with a false-negative reverse transcription p...
Autores principales: | Laloglu, Esra, Alay, Handan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Open Academia
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788653/ https://www.ncbi.nlm.nih.gov/pubmed/35140869 http://dx.doi.org/10.48101/ujms.v127.8211 |
Ejemplares similares
-
Role of transforming growth factor-beta 1 and connective tissue growth factor levels in coronavirus disease-2019-related lung Injury: a prospective, observational, cohort study
por: Laloglu, Esra, et al.
Publicado: (2022) -
Chest computed tomography in the diagnosis of COVID-19 in patients with false negative RT-PCR
por: Fonseca, Eduardo Kaiser Ururahy Nunes, et al.
Publicado: (2021) -
False negative RT-PCR and false positive antibody tests–Concern and solutions in the diagnosis of COVID-19
por: Jia, Xingwang, et al.
Publicado: (2021) -
Endocan as a prognostic biomarker of triple-negative breast cancer
por: Sagara, Atsunobu, et al.
Publicado: (2016) -
Does CT help in reducing RT-PCR false negative rate for COVID-19?
por: Kohli, Anirudh, et al.
Publicado: (2021)